Endoscopic Hemostasis Devices Market Size Worth USD 2,954.80 Million by 2034 | CAGR: 3.6%

The endoscopic hemostasis devices market size is expected to reach USD 2,954.80 million by 2034, according to a new study by Polaris Market Research. The report “Endoscopic Hemostasis Devices Market Size, Share, & Industry Analysis Report: By Product, By End Use (Hospitals and Outpatient Facilities), and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Endoscopic hemostasis devices are defined as minimally invasive instruments designed to control active gastrointestinal bleeding during endoscopies procedures. The devices are witnessing increased relevance amid the growing demand for precision-based therapeutics. The transition toward device miniaturization and improved maneuverability allows for greater access to difficult-to-reach bleeding sites with improved clinical outcomes. These advancements are allowing endoscopists to perform more targeted interventions with reduced patient discomfort and faster recovery times. The integration of compact, user-friendly medical devices has become a strategic priority as healthcare providers seek to improve procedural efficiency, further reinforcing their adoption across clinical settings.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/endoscopic-hemostasis-devices-market/request-for-sample

The integration of multifunctional technologies within single devices, combining clipping, coagulation, and injection capabilities into one system, further propels growth opportunities. This convergence of functionalities reduces procedural time and also minimizes the need for device exchange, improving workflow and safety during critical interventions. Additionally, the shift toward value-based care models is encouraging the adoption of versatile tools that can improve cost-efficiency while maintaining high standards of clinical effectiveness. Together, these trends are redefining the landscape of endoscopic bleeding management, aligning innovation with the evolving needs of the modern gastroenterological practice.

Top of FormEndoscopic Hemostasis Devices Market Report Highlights

• In terms of product, the ligation clips segment led the market in 2024, favored for their clinical efficacy, ease of use, and broad adoption in gastrointestinal bleeding management.
• Based on end use, the outpatient segment is anticipated to grow the fastest, driven by the shift toward minimally invasive techniques and cost-efficient healthcare solutions.
• In 2024, North America held the largest revenue share, supported by advanced healthcare systems, high adoption of minimally invasive procedures, and leading device manufacturers.
• The Asia Pacific endoscopic hemostasis devices market is expected to grow the fastest, propelled by increasing GI disorder prevalence, greater awareness of endoscopic treatments, and improving healthcare infrastructure.
• A few global key market players include Ambu A/S; Boston Scientific Corporation; CONMED Corporation; Cook Medical Inc.; FUJIFILM India Private Limited; HOYA Corporation (PENTAX Medical); Johnson & Johnson; KARL STORZ; Medtronic; MICRO-TECH (Nanjing) Co., Ltd.; Olympus America Inc.; Richard Wolf GmbH; Smith+Nephew; STERIS; and Stryker.

Polaris Market Research has segmented the endoscopic hemostasis devices market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Million, 2020–2034)

• Ligation Clips
• Ligation Bands
  • Hemorrhoidal
  • Esophageal
• Injection Needles
• Hemostatic Spray
• Thermal Probes
  • Contact Probes
  • Noncontact Probes
• Argon Plasma Coagulation (APC)
• Radiofrequency Ablation (RFA)

By End Use Outlook (Revenue, USD Million, 2020–2034)

• Hospitals
• Outpatient Facilities

By Regional Outlook (Revenue, USD Million, 2020–2034)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America